Literature DB >> 10077985

[Successful treatment of acute renal failure in a patient with essential mixed cryoglobulinemia using prednisolone and cryofiltration].

Y Wada1, T Saeki, S Miyamura, Y Osawa, M Ueno, S Nishi, M Arakawa.   

Abstract

We report a case of acute renal failure associated with cryoglobulinemic glomerulonephritis. The patient, a 49-year-old woman, was referred to our hospital because of acute nephritic syndrome. After admission, she developed oliguria, and hemodialysis was instituted. Renal biopsy was performed and the specimens showed moderate endocapillary proliferation, large deposits filling the capillary lumen ("intraluminal thrombi"), and a double-contoured appearance, which are typical morphologic features of cryoglobulinemic glomerulonephritis. Immunoelectrophoresis showed a monoclonal increase of IgM kappa. On the basis of these findings, we diagnosed type II essential mixed cryoglobulinemia. Cryofiltration was performed with oral administration of prednisolone. Following the start of therapy, the patient's renal function gradually improved. Because of severe hypoproteinemia, cryofiltration was discontinued after three sessions. However, renal function recovered and was maintained with prednisolone only. This case shows that acute oliguric renal failure caused by cryoglobulinemic glomerulonephritis can be reversible if immunosuppressive therapy, together with plasmapheresis in more severe cases, is instituted promptly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077985

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  1 in total

1.  Effectiveness of cryofiltration and mizoribine combination with oral steroid therapy in a patient with membranoproliferative glomerulonephritis due to essential cryoglobulinemia.

Authors:  Yuka Kurokawa; Kiyomi Koike; Yusuke Kaida; Sakuya Ito; Hirotane Chiba; Kengo Urae; Tomofumi Moriyama; Nao Nakamura; Tetsurou Imai; Ryo Shibata; Takuma Hazama; Daisuke Wakasugi; Seiya Okuda; Kei Fukami
Journal:  CEN Case Rep       Date:  2019-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.